| Heading: |
Prostate Cancer: Screening |
| Question ID: |
1824669 |
| UIN: |
HL9638 |
| House: |
Lords |
| Date tabled: |
2025-07-17 |
| Asking Member ID: |
1796 |
| Asking Member display name: |
Lord Taylor of Warwick
|
| Asking Member handle: |
Lord_ofWarwick
|
| Asking Member Twitter reference: |
@Lord_ofWarwick
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of how artificial intelligence can be used to analyse biopsy samples in patients with prostate cancer to help provide personalised treatment plans. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is testing artificial intelligence (AI) in the areas that cause the most harm to health and to our economy, including prostate cancer. Through the £113 million AI in Health and Care Award, 86 technologies have been supported, including thre... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |